Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: LVEF MORE THAN AND EQUAL TO 50 PERCENT
Exclusion criteria
Exclusion criteria: Mitral/aortic valve or other significant valve abnormalities Non-sinus rhythm Inotropic support/ IABP/hemodynamically unstable patient pre-operatively Patients on ventricular assist device Patients requiring conversion from off pump CABG to on pump CABG Critical left main coronary artery disease Intracardiac shunts Congenital Heart disease Redo surgery Patients with known contraindications for the insertion of TEE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Deceleration time of pulmonary vein diastolic wave (DT(D)) 2. Left atrial pressure (LAP) measured directly via needle insertionTimepoint: Immediately post sternotomy and 15 minutes after protamine administration | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Calculated LAP via E/e prime 2. Left Atrial Diameter 3. NT pro BNP levels Timepoint: Immediately post sternotomy & 15 minutes after protamine administration | — |
Countries
India
Contacts
GIPMER